Psychiatry AI scribe 2026: structured MSE, suicide risk, controlled-substance MAT, 42 CFR Part 2, and the solo workflow

May 9, 2026 · 7 min read

Psychiatry generates the longest narrative notes in medicine. A 60-minute initial evaluation can fill three pages with developmental history, trauma timeline, family psychiatric history, substance history, mental status exam, formulation, and plan. Solo and small-group psychiatrists — the majority of US outpatient psych delivery — spend two to four hours per day documenting after the last patient leaves. Generic ambient scribes capture conversation but fail the things psychiatry actually requires: a structured Mental Status Exam in clinically defensible language, standardized suicide risk assessment that holds up to malpractice review, controlled-substance prescribing rationale that satisfies DEA + state PMP audit, and the layered confidentiality of 42 CFR Part 2 when substance-use content is in the record.

The 2026 psychiatry-aware AI scribe stack handles five things: visit-type-aware schema (intake vs follow-up vs psychotherapy session), structured MSE with consistent vocabulary, standardized risk assessment (C-SSRS for suicidality, history-based for violence), controlled-substance + MAT documentation, and the time-on-psychotherapy capture that drives 90833 / 90836 / 90838 add-on coding when bundled with E/M.

Visit-type adaptation

Outpatient psychiatry has three core visit types with distinct documentation requirements:

• Initial psychiatric evaluation — 90791 (no medical) or 90792 (with medical). 60-90 min. Full developmental, trauma, substance, family psych, MSE, formulation, and plan.
• Medication management follow-up — E/M (99213/99214/99215) with optional psychotherapy add-on (+90833 / +90836 / +90838 by face-to-face psychotherapy time).
• Psychotherapy-only — 90832 (16-37 min), 90834 (38-52 min), 90837 (≥53 min). Time-based; documentation must support the time tier.

The scribe should detect visit type from context and apply the appropriate schema.

The psychiatry system prompt

You are documenting an outpatient psychiatry encounter.

INPUT:
- Encounter audio transcript
- Patient profile: prior diagnoses (DSM-5-TR), current meds with doses, prior MSE
- Active risk flags from prior visits (suicide attempt history, violence history, substance use)
- State PMP / PDMP recent controlled-substance fills

DETERMINE visit type, then apply schema:

For initial evaluation (90791/90792):
1. Chief complaint and HPI in patient's words + clinical synthesis
2. Past psychiatric history (hospitalizations, ECT, suicide attempts with dates/methods)
3. Substance use history (current + historical, route, last use, treatment episodes)
4. Trauma history (only what patient volunteered; do not infer)
5. Family psychiatric history
6. Developmental and social history
7. Medical history + current medications + allergies
8. Structured MSE (see template below)
9. Standardized risk assessment: C-SSRS (Columbia) for suicide; history + dynamic risk for violence
10. DSM-5-TR formulation with biopsychosocial factors
11. Treatment plan: meds (with rationale + monitoring), therapy modality, frequency, safety plan if indicated

For medication management follow-up:
1. Interval history since last visit
2. Target symptoms response (rate change vs prior visit)
3. Medication review (adherence, side effects, lab follow-up if indicated)
4. Brief MSE (delta from prior visit)
5. Risk reassessment if any concerning content
6. Plan: meds (continue/adjust/cross-taper with reasoning), labs, follow-up interval
7. If E/M+psychotherapy: capture psychotherapy time separately for add-on code

For psychotherapy:
1. Total session time (start/end timestamps)
2. Modality (CBT, DBT, supportive, psychodynamic, IPT, EMDR)
3. Themes / interventions
4. Patient response
5. Plan / homework

STRUCTURED MSE template:
Appearance, Behavior, Speech, Mood (patient-stated), Affect (clinician-observed),
Thought process, Thought content (including SI/HI/AVH/paranoia), Cognition
(orientation, attention, memory, abstract reasoning), Insight, Judgment.

CONTROLLED SUBSTANCE: if a stimulant, benzodiazepine, opioid, or buprenorphine
prescription is involved, document: medical necessity rationale, prior trials of
non-controlled alternatives, PMP review date, treatment agreement status,
pill count or UDS if applicable, and dose justification.

42 CFR PART 2: if substance-use treatment content is in the encounter, flag the
note as Part 2 protected; ensure no inappropriate disclosure language. Defer
release decisions to the clinician.

Cite transcript. Use clinically defensible language; do not paraphrase quotes
that affect risk determination.

Why structured MSE matters

Mental Status Exam is the most variable part of psychiatric documentation. Two psychiatrists describing the same patient can produce two different-sounding MSEs if the schema is inconsistent. A psychiatry-tuned scribe enforces vocabulary: affect: euthymic / dysphoric / blunted / restricted / labile / inappropriate; thought process: linear and goal-directed / circumstantial / tangential / loose associations / flight of ideas; insight: full / partial / poor. Consistent vocabulary makes the chart auditable across visits and across reviewing clinicians, and it produces defensible language when a malpractice case turns on whether mental status was adequately assessed.

Suicide risk: C-SSRS as the standard

Columbia Suicide Severity Rating Scale (C-SSRS) is the de facto standard for suicide risk documentation in 2026. The screening version asks ideation in the past month and any lifetime attempt; the full assessment captures intensity, plan, and intent. A psychiatry-aware scribe should always produce a C-SSRS-styled risk paragraph when ideation is present in the transcript, then layer the dynamic + static risk factors and an explicit risk stratification (low / moderate / high). Safety plan documentation, when needed, should follow Stanley-Brown format: warning signs, internal coping strategies, social distractions, social contacts for support, professional contacts, lethal means counseling.

Controlled substance and MAT

Stimulants for ADHD, benzodiazepines for anxiety (used cautiously), and buprenorphine / methadone for opioid use disorder all carry elevated documentation requirements. The note must justify medical necessity, document PMP / PDMP review (state-specific), capture treatment agreement status, and — for buprenorphine in OUD — document the X-waiver replacement pathway (post-MAT Act simplifications), induction details, and counseling/recovery support referrals. Generic scribes miss these elements; a psychiatry-tuned schema surfaces them as required fields.

42 CFR Part 2 confidentiality

Substance use disorder treatment records receive heightened federal confidentiality under 42 CFR Part 2, which is stricter than HIPAA. Any chart that contains SUD treatment content from a Part 2-covered program triggers special release requirements: patient written consent for each disclosure, exceptions for medical emergencies, and prohibition on use in criminal proceedings. The 2024 Final Rule (effective 2026) aligned Part 2 partly with HIPAA but kept the consent requirement. A psychiatry-aware scribe should flag charts with SUD content for Part 2 handling rather than letting the clinician miss it.

The solo psychiatrist economics

Solo and small-group psychiatry is the largest segment of US outpatient psych and the segment most underserved by enterprise ambient scribes. A solo psychiatrist seeing 18-22 patients per day at $300-450 per E/M+psychotherapy visit generates ~$1.5M annual collections but typically operates with one MA and no documentation staff. Subscription scribes at $200-300 per provider per month feel reasonable on paper but the floor (paying every month regardless of volume) misaligns with vacation, parental leave, and slow weeks. A pay-as-you-go DIY stack at $0.05/min Whisper = ~$3 per hour of patient time = ~$15-25 per day for a busy psychiatrist, with no floor on slow days. Over a year that's $4-6k vs $2.4-3.6k for subscription, but the variable-cost structure removes the friction of paying for unused capacity.

Vendor and DIY paths

Vendor ambient scribes (Suki, Heidi, DAX Copilot) work for psych mechanics — they capture conversation. They underdeliver on structured MSE vocabulary, C-SSRS-styled risk, controlled-substance audit fields, and Part 2 flagging unless the practice writes custom templates. The DIY stack — LessRec Whisper API + a psychiatry-tuned system prompt + your EHR's native templates — produces a defensible note in the structure malpractice carriers and Joint Commission auditors expect. The trade-off is build time (a weekend) and the willingness to iterate on the prompt as your style stabilizes.

BAA chain

Practice + EHR (NextGen Behavioral Health, Valant, SimplePractice, ICANotes) + transcription vendor + LLM vendor. For Part 2-covered SUD content, the chain must also support the heightened consent and disclosure controls or the practice should keep SUD content out of any vendor-touched layer.

When to start

Solo and small-group psychiatrists in 2026 have the strongest economic case for moving off subscription scribes onto a pay-as-you-go DIY stack: the volume is too variable, the documentation requirements (MSE structure, C-SSRS, controlled-substance audit, Part 2) are too specialty-specific, and the long narrative format of psychiatric notes is exactly where a tunable system prompt outperforms a vendor template. Start with intake notes (highest documentation burden) and follow-up med-management (highest visit volume); psychotherapy time-based notes can come last.